Coronavirus: does ‘V-Day’ mark the end of the pandemic?
UK woman becomes first person to receive Pfizer jab as NHS launches biggest-ever vaccination drive
A 90-year-old woman has become the the first person in the world to be vaccinated against Covid-19 outside of a clinical trial, as the largest mass vaccination drive in NHS history kicks off on what Health Secretary Matt Hancock has dubbed “V-Day”.
Grandmother-of-four Margaret Keenan received the Pfizer/BioNTech vaccine at 6.31am today at her local hospital in Coventry, after the UK government last week became the first to approve the jab for public use. Keenan, who turns 91 next week, said it was “the best early birthday present I could wish for” .
“I can finally look forward to spending time with my family and friends in the new year after being on my own for most of the year,” she added.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But does the vaccine launch herald imminent victory in the UK’s war against the coronavirus - or do more challenges lie ahead?
Vaccine rollout schedule
The UK government has so far received 800,000 of a total order for 40 million doses - enough for 20 million people - of the Pfizer/BioNTech vaccine, which needs to be stored at minus 70C.
A total of four million doses are on track to be delivered by the end of December, NHS Providers has told Sky News.
The vaccine is administered in two doses spaced 21 days apart, and will be offered first to people aged over 80, care home staff and some front-line NHS workers, at hospital hubs across the country.
Britain has also ordered 100 million doses of the Oxford/AstraZeneca vaccine candidate and seven million doses of the jab developed by Moderna - both of which are awaiting regulatory approval in the UK and other countries worldwide.
End in sight?
NHS England boss Simon Stevens says the deployment of the Pfizer vaccine “marks a decisive turning point in the battle with the pandemic”.
The vaccinations push will continue “at least until next spring”, he added, and unvaccinated people will need to be “very careful” in the meantime.
The rollout has also been welcomed by Keir Starmer, who this morning tweeted: “Today is a momentous day in our fight against Covid-19. There is light at the end of the tunnel.”
But like Stevens, the Labour leader sounded a note of caution, adding that “it is crucial we all continue to stay safe by following public health advice”.
Meanwhile, Health Secretary Hancock told BBC Breakfast: “We will look back on today, V-Day, as a key moment in our fight back against this terrible disease, and I am proud our health services across the United Kingdom are about to embark on our largest ever vaccination programme.”
However, there is a “long march ahead of us”, he said, adding: “This virus is deadly. We’ve got to stick by the rules.”
Danger remains
The government has today published a report highlighting the work and achievements of its Vaccines Taskforce (VTF), as Boris Johnson offers his thanks to NHS workers, the scientists who helped develop the vaccine, and the volunteers in the clinical trials.
“The approval of the Pfizer-BioNTech vaccine for use in the UK marks a momentous step in our fight against Covid-19,” the prime minister said. “But we still have some way to go and everyone needs to keep following the rules to keep the virus under control.”
The coronavirus has claimed more than 61,000 lives in the UK to date, and more than 1.5 million worldwide.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'Paraguay has found itself in a key position'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Meet Youngmi Mayer, the renegade comedian whose frank new memoir is a blitzkrieg to the genre
The Week Recommends 'I'm Laughing Because I'm Crying' details a biracial life on the margins, with humor as salving grace
By Scott Hocker, The Week US Published
-
Will Trump fire Fed chair Jerome Powell?
Today's Big Question An 'unprecedented legal battle' could decide the economy's future
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published